Quetiapine Tablet, Film Coated, Extended Release
Product Images NDC 50228-382

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 50228-382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Quetiapine Fumarate 150 mg 60 Count Label (Quetiapine 150mg)

Label for Quetiapine Extended-Release Tablets, USP 150 mg, oral film-coated tablets by ScieGen Pharmaceuticals, Inc. The label states '150 mg Once Daily' dosage with a quantity of 60 tablets. It includes instructions to swallow whole, storage conditions, and a reminder to keep out of reach of children. The NDC number 50228-381-60 and a barcode are also visible.*

FDA Label Image

Quetiapine Fumarate 200 mg 60 Count Label (Quetiapine 200mg)

Label for Quetiapine Extended-Release Tablets, USP 200 mg by ScieGen Pharmaceuticals Inc., containing 60 tablets. The label includes NDC 50228-382-60, directions to swallow whole, storage instructions, and a warning to keep out of reach of children. It specifies '200 mg Once Daily' dosage and Rx only status.*

FDA Label Image

Quetiapine Fumarate 300 mg 60 Count Label (Quetiapine 300mg)

Label for Quetiapine Extended-Release Tablets USP 300 mg oral tablets. The label indicates a 60-tablet count, with dosing instructions noting 300 mg once daily. Manufacturer is ScieGen Pharmaceuticals, Inc., Hauppauge, NY. Storage instructions specify 25°C (77°F) with permitted excursions. The label urges dispensing medication guide to each patient and displays a barcode and the NDC 50228-383-60.*

FDA Label Image

Quetiapine Fumarate 400 mg 60 Count Label (Quetiapine 400mg)

Label for Quetiapine Extended-Release Tablets USP 400 mg oral film-coated tablets, with a quantity of 60 tablets. Manufactured by ScieGen Pharmaceuticals, Inc. Directions note to swallow whole and take once daily. Storage instructions and a reminder to keep out of reach of children are included. The label features a barcode and a note to dispense the accompanying medication guide.*

FDA Label Image

Quetiapine Fumarate 50 mg 30 Count Bottle Label (Quetiapine 50mg)

Label for Quetiapine Extended-Release Tablets USP 50 mg oral tablet, film coated, extended release, by ScieGen Pharmaceuticals, Inc. The package contains 60 tablets and states the strength as 50 mg once daily. Storage instructions and a barcode are visible, along with warnings to not split, crush, or chew the tablets.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Schizophrenic Relapse Study 3.jpg (Quetiapine Fig01)

A Kaplan-Meier survival curve chart showing the proportion of patients with relapse (%) on the vertical axis over time in months on the horizontal axis. The chart compares two groups: one labeled PLA and the other QTP XR, with QTP XR showing a lower proportion of relapse over time.*

FDA Label Image

Figure 2 Kaplan-maier Curves Of Time To Recurrence Of A Mood Event.jpg (Quetiapine Fig02)

A line graph showing the proportion of patients with relapse (%) over time (weeks). Two groups are compared: CTP + LIVAL and PLA + LIVAL, with relapse rates increasing over the 100-week period.*

FDA Label Image

Figure 3 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 19).jpg (Quetiapine Fig03)

A line graph showing the proportion of patients with relapse (%) over time in weeks. Two lines are compared: one labeled QTP + LIVAL and the other PLA + LIVAL, depicting different patient groups' relapse rates during a study period up to 100 weeks.*

FDA Label Image

Structural Formula (Quetiapine Str)

Chemical structure of Quetiapine, the active ingredient in Quetiapine Extended Release tablets by ScieGen Pharmaceuticals, Inc. The image shows the molecular composition including aromatic rings, a thiophene moiety, and an ethoxy side chain, representing the characteristic structure of Quetiapine fumarate salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.